高通量血液透析对老年患者营养及体能状况的影响

黄继义; 张俊

doi:10.7619/jcmp.201321052

高通量血液透析对老年患者营养及体能状况的影响

黄继义,
张俊

厦门大学第一附属医院同民分院,福建厦门,361000

详细信息

中图分类号: R459.5
计量
- 文章访问数: 141
- HTML全文浏览量: 11
- PDF下载量: 0
出版历程
- 发布日期: 2014-04-07

摘要

摘要: 血液透析(Hemodialysis)简称血透,是血液净化技术的一种[1],其基本原理是利用半透膜通过扩散将流体内各种有害以及多余的代谢废物和过多的电解质移出体外,达到净化血液的目的,并达到纠正水电解质及酸碱平衡的目的[1].目前,血液透析是维持终末期肾病患者生命的最常用治疗手段.随着中国人口老龄化的加剧以及透析技术的发展与普及,终末期肾病患者的数量在增多,需要血液透析维持生命的患者亦呈现逐年增多的趋势[2-3].终末期肾病患者的生存时间在不断延长[4-5].在此情况下,维持透析患者的长期存活质量越来越受到重视,如何提高透析患者的生存时间及生活质量是一项十分有意义的临床课题.
- 血液透析 /
- 老年 /
- 终末期肾病 /
- 营养

HTML全文

参考文献(19)

Zhao D, Sun X, Yao L. The Clinical Significance and Risk Factors of Anti-Platelet Factor 4/heparin Antibody on Maintenance Hemodialysis Patients:A Two-Year Prospective Follow-up [J]. PLOS ONE, 2013(4):e62239.

Lang C L, Wang M H, Hung K Y. Altered molecular repertoire of immune system by renal dysfunction in the elderly:is prediction and targeted prevention in the horizon [J]. EPMAJ, 2013(1):17.

兰雷, 汪鹏, 刁秀竹. 维持性血液透析患者的临床流行病学变迁 [J]. {H}中国血液净化, 2012(5):280.doi: 10.3969/j.issn.1671-4091.2012.05.013.

Afsar B. The relationship between depressive symptoms and erythropoietin resistance in stable hemodialysis patients with adequate iron stores [J]. {H}International Journal of Artificial Organs, 2013(5):314.

Florence G, Carine H, Julien A. The clinical status and survival in elderly dialysis:example of the oldest region of France [J]. {H}BMC Nephrology, 2013(1):131.

Gomis-Couto A, Elias S, Fernandez-Lucas M. On-Line haemodialfiltration versus high flux haemodialysis [J]. {H}NEFROLOGIA, 2012(5):680.

Sawires H K, Mohamed W A, Schaalan M F. High-flux and low-flux dialysis membranes and levels of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in children with chronic kidney failure [J]. Iran J Kidney Dis, 2012(5):366.

Einollahi B, Alavian SM. Hepatitis B virus infection:need for more attention in hemodialysis patients [J]. Saudi J Kidney Dis Transpl, 2013(3):587.

陈凤锟, 李冀军. 2008年度北京地区血液透析患者透析龄调查分析 [J]. {H}中国血液净化, 2011(4):185.doi: 10.3969/j.issn.1671-4091.2011.04.004.

Hothi D K, Rees L, McIntyre C W. HemodialysisInduced Acute Myocardial Dyssynchronous Impairment in Children [J]. {H}NEPHRON CLINICAL PRACTICE, 2013, (1/2):83.

Torato T, Doi K, Negishi K. Efficacy of Vitamin E-bonded Polysulfone Dialyzer and Polysulfone Dialyzer on a Series of Non-anticoagulant Hemodialysis [J]. {H}ASAIO Journal, 2013(3):284.

向元兵, 屈智慧, 杨立志. 老年血液透析患者死亡因素分析 [J]. {H}中国老年学杂志, 2012(6):1245.doi: 10.3969/j.issn.1005-9202.2012.06.062.

Melamed ML, Plantinga L, Shafi T. Retained organic solutes, patient characteristics and all-cause and cardiovascular mortality in hemodialysis:results from the retained organic solutes and clinical outcomes (ROSCO) investigators [J]. {H}BMC Nephrology, 2013(1):134.

Chen J, Peng H, Yuan Z. Combination with Anthropometric Measurements and MQSGA to Assess Nutritional Status in Chinese Hemodialysis Population [J]. {H}International Journal of Medical Sciences, 2013(8):974.

Hussain M, HashmiAH, Rizvi SA. Problems and Prospects of Neglected Renal Calculi in Pakistan:Can This Tragedy be Averted [J]. Urol J, 2013(2):848.

Ok E, Asci G, Toz H. Mortality and cardiovascular events in online haemodiafiltration (OL-HDF) compared with high-flux dialysis:results from the Turkish OL-HDF Study [J]. {H}Nephrology Dialysis Transplantation, 2013(1):192.

Azak A, Huddam B, Onec K. Contribution of high flux membranes to the therapy of uremia-associated dyslipidemia [J]. {H}THERAPEUTIC APHERESIS AND DIALYSIS, 2012(6):595.

Kantartzi K, Panagoutsos S, Mourvati E. Can dialysis modality influence quality of life in chronic hemodialysis patients? Low-flux hemodialysis versus high-flux hemodiafiltration:a cross-over study [J]. {H}Renal Failure, 2013(2):216.

Khadzhynov D, Slowinski T, Lieker I. Pharmacokinetics of aliskiren in patients with end-stage renal disease undergoing haemodialysis [J]. {H}Clinical Pharmacokinetics, 2012, (10):661.